Modulation of immune responses following antigen administration by mucosal route

FEMS Immunology and Medical Microbiology

Volumn 27, Issue 4, 2000, Pages 305-311

  Medina, Eva ^a   Guzmán, Carlos Alberto ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Adjuvant; Antigen delivery; Immune response; Live carrier; Mucosal vaccine

Indexed keywords

CYTOKINE; DIPHTHERIA TOXOID; DNA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; LIPOSOME; TETANUS TOXOID;

ARTICLE; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOSTIMULATION; LISTERIA MONOCYTOGENES; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; SALMONELLA; TRANSGENIC PLANT; VACCINATION; VIRUS PARTICLE; VIRUS RECOMBINANT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; HUMANS; IMMUNITY, MUCOSAL; VACCINATION; VACCINES; VACCINES, DNA;

EID: 0034064562     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(99)00208-4     Document Type: Article

References (87)

1. Levine M.M., Kaper J.B., Black R.E., Clements M.L. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development. Microbiol. Rev. 47:1983;510-550.
2. McGhee J.R., Mestecky J., Dertzbaugh M.T., Eldridge J.H., Hirasawa M., Kiyono H. The mucosal immune system: from fundamental concepts to vaccine development. Vaccine. 10:1992;75-88.
3. Kissel T., Koneberg R., Hilbert A.K., Hungerer K.D. Microencapsulation of antigens using biodegradable polyester: facts and phantasies. Behring Inst. Mitt. 98:1997;172-183.
4. Kim S.Y., Doh H.J., Ahn J.S., Ha Y.J., Jang M.H., Chung S.I., Park H.J. Induction of mucosal and systemic immune response by oral immunization with H. pylori lysates encapsulated in poly(D,L-lactide-co-glycolide) microparticles. Vaccine. 17:1999;607-616.
5. Chattaraj S.C., Rathinavelu A., Das S.K. Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice. J. Control. Release. 58:1999;223-232.
6. Flanagan M.P., Michael J.G. Oral immunization with a Streptococcal pneumoniae polysaccharide conjugate vaccine in enterocoated microparticles induces serum antibodies against type specific polysaccharide. Vaccine. 17:1999;72-81.
7. Chen S.C., Jones D.H., Fynan E.F., Farrar G.H., Clegg J.C., Greenberg H.B., Herrmann J.E. Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J. Virol. 72:1998;5757-5761.
8. Jones D.H., Clegg J.C., Farrar G.H. Oral delivery of micro-encapsulated DNA vaccines. Dev. Biol. Stand. 92:1998;149-155.
9. Holmgren J., Lycke N., Czerkinsky C. Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector system. Vaccine. 1993:1993;1179-1184.
10. Douce G., Turcotte C., Cropley I., Roberts M., Pizza M., Domenghini M., Rappuoli R., Dougan G. Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc. Natl. Acad. Sci. USA. 92:1995;1644-1648.
11. Snider D.P., Marshall J.S., Perdue M.H., Liang H. Production of IgE antibody and allergic sensitization of intestinal and peripheral tissues after oral immunization with protein antigen and cholera toxin. J. Immunol. 153:1994;647-657.
12. Giuliani M.M., Del Giudice G., Giannelli V., Dougan G., Douce G., Rappuoli R., Pizza M. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J. Exp. Med. 187:1998;1123-1132.
13. Yamamoto S., Takeda Y., Yamamoto M., Kurazono H., Imaoka K., Yamamoto M., Fujihashi K., Noda M., Kiyono H., McGhee J.R. Mutants in the ADP-ribosyltransferase cleft of cholera toxin lack diarrheagenicity but retain adjuvanticity. J. Exp. Med. 185:1997;1203-1210.
14. Medina E., Talay S.R., Chhatwal G.S., Guzmán C.A. Fibronectin-binding protein I of Streptococcus pyogenes is a promising adjuvant for antigens delivered by mucosal route. Eur. J. Immunol. 28:1998;1069-1077.
15. Medina E., Talay S.R., Chhatwal G.S., Guzmán C.A. Fibronectin-binding protein I of Streptococcus pyogenes promotes T cell-independent proliferation of murine B lymphocytes and enhances the expression of HMC class II molecules on antigen-presenting cells. Int. Immunol. 10:1998;1657-1664.
16. Rosenberg S.A., Yang J.C., Schwartzentruber D.J., Hwu P., Marincola F.M., Topalian S.L., Restifo N.P., Sznol M., Schwarz S.L., Spiess P.J., Wunderlich J.R., Seipp C.A., Einhorn J.H., Rogers-Freezer L., White D.E. Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine. J. Immunol. 163:1999;1690-1695.
17. Operschall E., Schuh T., Heinzerling L., Pavlovic J., Moelling K. Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice. J. Clin. Virol. 13:1999;17-27.
18. Larsen D.L., Dybdahl-Sissoko N., McGregor M.W., Drape R., Neumann V., Swain W.F., Lunn D.P., Olsen C.W. Coadministration of DNA encoding interleukin-6 and hemagglutinin confers protection from influenza virus challenge in mice. J. Virol. 72:1998;1704-1708.
19. Staats H.F., Ennis F.A. Jr. IL-1 is an effective adjuvant for mucosal and systemic immune responses when coadministered with protein immunogens. J. Immunol. 162:1999;6141-6147.
20. Pasquini S., Xiang Z., Wang Y., He Z., Deng H., Blaszczyk-Thurin M., Ertl H.C. Cytokines and costimulatory molecules as genetic adjuvants. Immunol. Cell. Biol. 75:1997;397-401.
21. Klinman D.M., Barnhart K.M., Conover J. CpG motifs as immune adjuvants. Vaccine. 17:1999;19-25.
22. Lipford G.B., Heeg K., Wagner H. Bacterial DNA as immune cell activator. Trends Microbiol. 6:1998;496-500.
23. Ulrich R., Nassal M., Meisel H., Kruger D.H. Core particles of hepatitis B virus as carrier for foreign epitopes. Adv. Virus Res. 50:1998;141-182.
24. Milich D.R., Peterson D.L., Zheng J., Hughes J.L., Wirtz R., Schodel F. The hepatitis nucleocapsid as vaccine carrier moiety. Ann. N.Y. Acad. Sci. 754:1995;187-201.
25. Fehr T., Skrastina D., Pumpens P., Zinkernagel R.M. T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc. Natl. Acad. Sci. USA. 95:1998;9477-9481.
26. Sinha R.K., Khuller G.K. The protective efficacy of a liposomal encapsulated 30 kDa secretory protein of Mycobacterium tuberculosis H37Ra against tuberculosis in mice. Immunol. Cell Biol. 75:1997;461-466.
27. Lachman L.B., Ozpolat B., Rao X.M. Cytokine-containing liposomes as vaccine adjuvants. Eur. Cytokine Netw. 7:1996;693-698.
28. Okada E., Sasaki S., Ishii N., Aoki I., Yasuda T., Nishioka K., Fukushima J., Miyazaki J., Wahren B., Okuda K. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens. J. Immunol. 159:1997;3638-3647.
29. Ambrosch F., Wiedermann G., Jonas S., Althaus B., Finkel B., Gluck R., Herzog C. Immunogenicity and protectivity of a new liposomal hepatitis A vaccine. Vaccine. 15:1997;1209-1213.
30. Okamoto T., Kaneda Y., Yuzuki D., Huang S.K., Chi D.D., Hoon D.S. Induction of antibody response to human tumor antigens by gene therapy using a fusigenic viral liposome vaccine. Gene Ther. 4:1997;969-976.
31. Kwak L.W., Pennington R., Boni L., Ochoa A.C., Robb R.J., Popescu M.C. Liposomal formulation of a self lymphoma antigen induces potent protective antitumor immunity. J. Immunol. 160:1998;3637-3641.
32. Afrin F., Ali N. Adjuvancity and protective immunity elicited by Leishmania donovani antigens encapsulated in positively charged liposomes. Infect. Immun. 65:1997;2371-2377.
33. de Haan A., Tomee J.F., Huchshorn J.P., Wilschut J. Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice. Vaccine. 13:1995;1320-1324.
34. Cryz S.J. Jr., Gluck R. Immunopotentiating reconstituted influenza virosomes as a novel antigen delivery system. Dev. Biol. Stand. 92:1998;219-223.
35. Gluck R. Adjuvant activity of immunopotentiating reconstituted influenza virosomes (IRIVs). Vaccine. 17:1999;1782-1787.
36. Morein F., Bengtsson K.L. Functional aspects of ISCOMs. Immunol. Cell Biol. 76:1998;295-299.
37. Mowat A.M., Smith R.E., Donachie A.M., Furrie E., Grdic D., Lycke N. Oral vaccination with immune stimulating complexes. Immunol. Lett. 65:1999;133-140.
38. Smith R.E., Donachie A.M., Mowat A.M. Immune stimulating complexes as mucosal vaccines. Immunol. Cell Biol. 76:1998;263-269.
39. Haq T.A., Mason H.S., Clements J.D., Arntzen C.J. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science. 268:1995;714-716.
40. McCormick A.A., Kumagai M.H., Hanley K., Turpen T.H., Hakin I., Grill L.K., Tuse D., Levy S., Levy R. Rapid production of specific vaccines for lymphoma by expression of the tumor-derived single-chain Fv epitopes in tobacco plants. Proc. Natl. Acad. Sci. USA. 19:1999;703-708.
41. Tacket C.O., Mason H.S., Losonsky G., Clements J.D., Levine M.M., Arntzen C.J. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato. Nat. Med. 4:1998;607-609.
42. Arakawa T., Yu J., Langridge W.H. Food plant-delivered cholera toxin B subunit for vaccination and immunotolerization. Adv. Exp. Med. Biol. 464:1999;161-178.
43. Simth G., Walmsley A., Polkinghorne I. Plant-derived immunocontraceptive vaccines. Reprod. Fertil. Dev. 9:1997;85-89.
44. Curtiss R. III, Kelly S.M., Tinge M.A., Tacket C.O., Levine M.M., Srinivasan J., Koopman M. Recombinant Salmonella vectors in vaccine development. Dev. Biol. Stand. 82:1994;23-33.
45. Everest P., Griffiths P., Dougan G. Live Salmonella vaccines as a route towards oral immunizations. Biologicals. 23:1995;119-124.
46. Schodel F., Curtiss R. III. Salmonellae as oral vaccine carriers. Dev. Biol. Stand. 84:1995;245-253.
47. Hoiseth S.K., Stocker B.A.D. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature. 291:1981;238-239.
48. O'Callaghan D., Maskell D., Liew F.Y., Easmon C.S.F., Dougan G. Characterization of aromatic- and purine-dependent Salmonella typhimurium: attenuation, persistence, and ability to induce protective immunity in BALB/c mice. Infect. Immun. 56:1988;419-423.
49. Curtiss R. III, Kelly S.M. Salmonella typhimurium deletion mutants lacking adenylate cyclase and cyclic AMP receptor protein are avirulent and immunogenic. Infect. Immun. 55:1987;3035-3043.
50. Galán J.E., Curtiss R. III. Virulence and vaccine potential of phoP mutants of Salmonella typhimurium. Microb. Pathog. 6:1989;433-443.
51. Medina E., Paglia P., Nikolaus T., Müller A., Hensel M., Guzmán C.A. Pathogenicity Island 2 mutants of Salmonella typhimurium are efficient carriers for heterologous antigens and enable modulation of immune responses. Infect. Immun. 67:1999;1093-1099.
52. Brown A., Hormaeche C.E., Demarco de Hormaeche R., Winther M., Dougan G., Maskell D.J., Stocker B.A.D. An attenuated aroA Salmonella typhimurium vaccine elicits humoral and cellular immunity to cloned β-galactosidase in mice. J. Infect. Dis. 155:1987;86-91.
53. Flynn J.L., Weiss W.R., Norris K.A., Seifert H.S., Kumar S., So M. Generation of a cytotoxic T-lymphocyte response using Salmonella antigen-delivering system. Mol. Microbiol. 4:1990;2111-2118.
54. Dunstan S.J., Cameron P.S., Strugnell R.A. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen. Infect. Immun. 66:1998;732-740.
55. Guzmàn C.A., Brownlie R.M., Kadurugamuwa J., Walker M.J., Timmis K.N. Antibody responses in the lungs of mice following oral immunization with Salmonella typhimurium aroA and invasive Escherichia coli strains expressing the filamentous hemagglutinin of Bordetella pertussis. Infect. Immun. 59:1991;4391-4397.
56. Medina E., Guzmán C.A., Colombo M.P., Paglia P. Salmonella vaccine carrier strains: effective delivery system to trigger anti-tumor immunity by oral route. Eur. J. Immunol. 29:1999;693-699.
57. Guzmán, C.A., Weiss, S. and Chakraborty, T. (1997) Listeria monocytogenes-a promising vaccine carrier to evoke cellular immune responses. In: Gram-Positive Bacteria as Vaccine Vehicles for Mucosal Immunization (Pozzi, G. and Wells, J., Eds.), pp. 145-173. Landes Biosciences, Austin, TX.
58. Weiskirch L.M., Paterson Y. Listeria monocytogenes: a potent vaccine vector for neoplastic and infectious disease. Immunol. Rev. 158:1997;159-169.
59. Jensen E.R., Shen H., Wettstein F.O., Ahmed R., Miller J.F. Recombinant Listeria monocytogenes as a live vaccine vehicle and a probe for studying cell-mediated immunity. Immunol. Rev. 158:1997;147-157.
60. Paglia P., Arioli I., Frahm N., Chakraborty T., Colombo M.P., Guzmán C.A. The defined attenuated Listeria monocytogenes Δ mp12 mutant is an effective oral vaccine carrier to trigger a long-lasting immune response against a mouse fibrosarcoma. Eur. J. Immunol. 27:1997;1570-1575.
61. Slifka M.K., Shen H., Matloubian M., Jensen E.R., Miller J.F., Ahmed R. Antiviral cytotoxic T-cell memory by vaccination with recombinant Listeria monocytogenes. J. Virol. 70:1996;2902-2910.
62. Jensen E.R., Selvakumar R., Shen H., Amed R., Wettstein F.O., Miller J.F. Recombinant Listeria monocytogenes vaccination eliminates papillomavirus-induced tumors and prevents papilloma formation from viral DNA. J. Virol. 71:1997;8467-8474.
63. Ikonomidis G., Portnoy D.A., Gerhard W., Paterson Y. Influenza-specific immunity induced by recombinant Listeria monocytogenes vaccines. Vaccine. 15:1997;433-440.
64. Pan Z.K., Ikonomidis G., Lazenby A., Pardoll D., Paterson Y. A recombinant Listeria monocytogenes vaccine expressing a model tumour antigen protects mice against lethal tumour cell challenge and causes regression of established tumours. Nat. Med. 1:1995;471-477.
65. Favre D., Cryz S.J. Jr., Viret J.K. Development of Shigella sonnei live oral vaccines based on defined rfb Inaba deletion mutants of Vibrio cholerae expressing the Shigella serotype D O polysaccharide. Infect. Immun. 64:1996;576-584.
66. Klee S.R., Tzschaschel B.D., Fält I., Kärnell A., Lindberg A.A., Timmis K.N., Guzmán C.A. Construction and characterization of live attenuated vaccine candidates against Shigella dysenteriae type 1. Infect. Immun. 65:1997;2112-2118.
67. Kotloff K.L., Herrington D.A., Hale T.L., Newland J.W., Van De Verg L., Cogan J.P., Snoy P.J., Sadoff J.C., Formal S.B., Levine M.M. Safety, immunogenicity, and efficacy in monkeys and humans of invasive Escherichia coli K-12 hybrid vaccine candidates expressing Shigella flexneri 2a somatic antigen. Infect. Immun. 60:1992;2218-2224.
68. Pozzi, G., Oggioni, M.R. and Medaglini, D. (1997) Recombinant Streptococcus gordonii as live vehicle for vaccine antigens. In: Gram-Positive Bacteria as Vaccine Vehicles for Mucosal Immunization (Pozzi, G. and Wells, J., Eds.), pp. 35-60. Landes Biosciences, Austin, TX.
69. Chamberlain, L., Wells, J.M., Robinson, K., Schofield, K. and Le Page, R. (1997) Mucosal immunization with recombinant Lactobacillus lactis. In: Gram-Positive Bacteria as Vaccine Vehicles for Mucosal Immunization (Pozzi, G. and Wells, J., Eds.), pp. 83-106. Landes Biosciences, Austin, TX.
70. VanCott J.L., Chatfield S.N., Roberts M., Hone D.M., Hohmann E.L., Pascual D.W., Yamamoto M., Kiyono H., McGhee J.R. Regulation of host immune responses by modification of Salmonella virulence genes. Nat. Med. 4:1998;1247-1252.
71. Hess J., Gentschev I., Miko D., Welzel M., Ladel C., Goebel W., Kaufmann S.H. Superior efficacy of secreted over somatic antigen display in recombinant Salmonella vaccine induced protection against listeriosis. Proc. Natl. Acad. Sci. USA. 93:1996;1458-1463.
72. + T cells. Eur. J. Immun. 28:1998;1807-1814.
73. Tzschaschel B.D., Guzmán C.A., Timmis K.N., de Lorenzo V. An Escherichia coli hemolysin transport system-based vector for the export of polypeptides: export of shiga-like toxin IIe B subunit by Salmonella typhimurium aroA. Nat. Biotechnol. 14:1996;765-769.
74. Gentschev I., Mollenkopf H., Sokolovic Z., Hess J., Kaufmann S.H., Goebel W. Development of antigen-delivery systems, based on the Escherichia coli hemolysin pathway. Gene. 179:1996;133-140.
75. Spreng S., Dietrich G., Goebel W., Gentschev I. The Escherichia coli haemolysin secretion apparatus: a potential universal antigen delivery system in Gram-negative bacterial vaccine carriers. Mol. Microbiol. 31:1999;1596-1598.
76. Russmann H., Shams H., Poblete F., Fu Y., Galan J.E., Donis R.O. Delivery of epitopes by the Salmonella type III secretion system for vaccine development. Science. 281:1998;565-568.
77. Fu T.M., Guan L., Friedman A., Schofield T.L., Ulmer J.B., Liu M.A., Donnelly J.J. Dose dependence of CTL precursor frequency induced by a DNA vaccine and correlation with protective immunity against influenza virus challenge. J. Immunol. 162:1999;4163-4170.
78. Lai W.C., Bennett M. DNA vaccines. Crit. Rev. Immunol. 18:1998;449-484.
79. Alarcon J.B., Waine G.W., McManus D.P. DNA vaccines: technology and application as anti-parasite and anti-microbial agents. Adv. Parasitol. 42:1999;343-410.
80. Webster R.G. Potential advantages of DNA immunization for influenza epidemic and pandemic planning. Clin. Infect. Dis. 28:1999;225-229.
81. Syrengelas A.D., Levy R. DNA vaccination against the idiotype of a murine B cell lymphoma: mechanism of tumor protection. J. Immunol. 162:1999;4790-4795.
82. Kucerova L. DNA/genetic vaccination. Viral Immunol. 11:1998;55-63.
83. Berglund P., Smerdou C., Fleeton M.N., Tubulekas I., Liljestrom P. Enhancing immune responses using suicidal DNA vaccines. Nat. Biotechnol. 16:1998;562-565.
84. Paglia P., Medina E., Airoli I., Guzmán C.A., Colombo M. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood. 92:1998;3172-3176.
85. Darji A., Guzmán C.A., Gerstel B., Wachholz P., Timmis K.N., Wehland J., Chakraborty T., Weiss S. Oral somatic transgene vaccination using attenuated Salmonella typhimurium. Cell. 91:1997;765-775.
86. Sizemore D.R., Branstrom A.A., Sadoff J.C. Attenuated Shigella as a DNA delivery vehicle for DNA-mediated immunization. Science. 270:1995;299-302.
87. Dietrich G., Bubert A., Gentschev I., Sokolovic Z., Simm A., Catic A., Kaufmann S.H., Hess J., Szalay A.A., Goebel W. Delivery of antigen-encoding plasmid DNA into the cytosol of macrophages by attenuated suicide Listeria monocytogenes. Nat. Biotechnol. 16:1998;181-185.